Giordano Christopher Thomas bought TENX
January 9, 2026 · Form 4 insider transaction
Giordano Christopher Thomas bought 450,000 shares of Tenax Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
450,000
Price
$0.00
Total value
N/A
InsiderGiordano Christopher Thomas
RoleOfficer, Director
SecurityStock Option (right to buy)
Transaction codeA: Grant or award
Transaction dateJanuary 9, 2026
Filing dateJanuary 13, 2026
Shares owned after450,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The options vest and become exercisable as follows: 25% of the underlying shares of common stock vest and become exercisable on January 9, 2027, and thereafter 1/36th of the remaining shares will vest on the last day of each following month for a period of 36 months, subject to the Reporting Person's continued employment.